Capital World Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $35.8M | Sell |
|
|||||
|
2024
Q1 | $68.6M | Buy |
|
|||||
|
2023
Q4 | $105M | Sell |
|
|||||
|
2023
Q3 | $137M | Buy |
|
|||||
|
2023
Q2 | $242M | Sell |
|
|||||
|
2023
Q1 | $325M | Buy |
|
|||||
|
2022
Q4 | $175M | Buy |
|
|||||
|
2022
Q3 | $217M | Buy |
|
|||||
|
2022
Q2 | $63.4M | Buy |
|
|||||
|
2022
Q1 | $65.3M | Sell |
|
|||||
|
2021
Q4 | $60.6M | Buy |
|
|||||
|
2021
Q3 | $82.7M | Hold |
|
|||||
|
2021
Q2 | $87.9M | Buy |
|
|||||
|
2021
Q1 | $71.9M | Buy |
|
|||||
|
2020
Q4 | $60.4M | Hold |
|
|||||
|
2020
Q3 | $53.5M | Hold |
|
|||||
|
2020
Q2 | $52M | Hold |
|
|||||
|
2020
Q1 | $31.5M | Hold |
|
|||||
|
2019
Q4 | $34.6M | Buy |
|
|||||
|
2019
Q3 | $21.9M | Hold |
|
|||||
|
2019
Q2 | $21.9M | Hold |
|
|||||
|
2019
Q1 | $26.6M | Buy |
|
|||||
|
2018
Q4 | $24.7M | Hold |
|
|||||
|
2018
Q3 | $30.4M | Sell |
|
|||||
|
2018
Q2 | $39.4M | Buy |
|